Healios K.K. (OTCMKTS:HLOSF) Short Interest Update

Healios K.K. (OTCMKTS:HLOSFGet Free Report) saw a significant increase in short interest in the month of January. As of January 15th, there was short interest totalling 340,500 shares, an increase of 15.5% from the December 31st total of 294,800 shares. Based on an average daily volume of 1,300 shares, the days-to-cover ratio is currently 261.9 days.

Healios K.K. Stock Performance

OTCMKTS HLOSF opened at 1.11 on Wednesday. Healios K.K. has a one year low of 1.10 and a one year high of 1.31. The firm’s fifty day moving average is 1.45 and its two-hundred day moving average is 6.47.

About Healios K.K.

(Get Free Report)

Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company offers HLCM051 for treatment of ischemic stroke and acute respiratory distress syndrome; HLCN061 for treating solid tumors; HLCR011 for the treatment of retinal pigment epithelium tear and age-related macular degeneration; and HLCL041 for liver disease.

Featured Articles

Receive News & Ratings for Healios K.K. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healios K.K. and related companies with MarketBeat.com's FREE daily email newsletter.